Kala Pharmaceuticals, Inc., a leading developer of innovative products that enhance penetration of therapeutic agents into ocular tissue based on the Company’s proprietary Mucus Penetrating Particle (MPP) technology, today announced the appointment of Howard B. Rosen as Chairman of the company’s board of directors.
Help employers find you! Check out all the jobs and post your resume.
